Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ANCA Associated Vasculitis (AAV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Not applicableLooking for participantsNCT07150000
What this trial is testing

Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy

Who this might be right for
Rheumatic DiseasesRheumatoid Arthritis (RA)Giant Cell Arteritis (GCA)+10 more
University of Bonn 120
Testing effectiveness (Phase 2)Looking for participantsNCT07800871
What this trial is testing

FT839 in Autoimmune Diseases

Who this might be right for
ANCA-Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Rheumatoid Arthritis (RA)+2 more
Fate Therapeutics 446
Testing effectiveness (Phase 2)Looking for participantsNCT06828042
What this trial is testing

Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErthematosusSystemic Sclerosis (SSc)Sjogren Syndrome+3 more
Peking University Third Hospital 9
Testing effectiveness (Phase 2)Ended earlyNCT03712345
What this trial is testing

Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA

Who this might be right for
Granulomatosis With Polyangiitis (GPA)Microscopic Polyangiitis (MPA)
InflaRx GmbH 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06868290
What this trial is testing

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

Who this might be right for
ANCA Associated Vasculitis (AAV)
Novartis Pharmaceuticals 126
Not applicableLooking for participantsNCT06642870
What this trial is testing

Rare AutoImmune SElf-management Programme Development

Who this might be right for
Systemic Lupus ErthematosusSystemic VasculitisInflammatory Myositis+3 more
University of the West of England 360
Not applicableLooking for participantsNCT06614270
What this trial is testing

Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases

Who this might be right for
Systemic Sclerosis (SSc)ANCA Associated Vasculitis (AAV)Idiopathic Inflammatory Myopathy (IIM)+3 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 15
Large-scale testing (Phase 3)Looking for participantsNCT07168161
What this trial is testing

BDB-001 Phase III Trial in ANCA-Associated Vasculitis

Who this might be right for
ANCA Associated Vasculitis (AAV)
Staidson (Beijing) Biopharmaceuticals Co., Ltd 300
Testing effectiveness (Phase 2)Looking for participantsNCT07089121
What this trial is testing

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

Who this might be right for
Childhood-onset Systemic Lupus ErythematousANCA-Associated Vasculitis (AAV)Juvenile Myasthenia Gravis+1 more
Cartesian Therapeutics 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06226662
What this trial is testing

Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)

Who this might be right for
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
NovelMed Therapeutics 12
Post-approval studies (Phase 4)Looking for participantsNCT06072482
What this trial is testing

Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Who this might be right for
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Amgen 300